Conversely, Slebos reported a series of 69 surgically treated adenocarcinomas of the lung in which K-RAS codon-12 point mutations resulted in a negative prognostic factor for disease-free survival (P = 0.038) and overall survival (P = 0.002) [29]. The gene discussed is KRAS; the disease is lung adenocarcinoma.